Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial.
Banning AS, Adriaenssens T, Berry C, Bogaerts K, Erglis A, Distelmaier K, Guagliumi G, Haine S, Kastrati A, Massberg S, Orban M, Myrmel T, Vuylsteke A, Alfonso F, Van de Werf F, Verheugt F, Flather M, Sabaté M, Vrints C, Gershlick AH; Collaborators. Banning AS, et al. Among authors: bogaerts k. EuroIntervention. 2021 Feb 5;16(15):e1227-e1236. doi: 10.4244/EIJ-D-20-01076. EuroIntervention. 2021. PMID: 33106225 Free PMC article. Clinical Trial.
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, Gelev V, Rumoroso JR, Erglis A, Christiansen EH, Escaned J, di Mario C, Hovasse T, Teruel L, Bufe A, Lauer B, Bogaerts K, Goicolea J, Spratt JC, Gershlick AH, Galassi AR, Louvard Y; EUROCTO trial investigators. Werner GS, et al. Among authors: bogaerts k. Eur Heart J. 2018 Jul 7;39(26):2484-2493. doi: 10.1093/eurheartj/ehy220. Eur Heart J. 2018. PMID: 29722796 Clinical Trial.
ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.
Sinnaeve PR, Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Lambert Y, Danays T, Soulat L, Halvorsen S, Ortiz FR, Vandenberghe K, Regelin A, Bluhmki E, Bogaerts K, Van de Werf F; STREAM investigators. Sinnaeve PR, et al. Among authors: bogaerts k. Circulation. 2014 Sep 30;130(14):1139-45. doi: 10.1161/CIRCULATIONAHA.114.009570. Epub 2014 Aug 26. Circulation. 2014. PMID: 25161043 Clinical Trial.
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study.
Varenne O, Cuisset T, Chaïb A, Morice MC, Sabaté M, Koh TH, Durand-Zaleski I, Hanon O, Bogaerts K, Sinnaeve P. Varenne O, et al. Among authors: bogaerts k. EuroIntervention. 2017 Jan 20;12(13):1614-1622. doi: 10.4244/EIJY15M12_02. EuroIntervention. 2017. PMID: 26690312 Free article. Clinical Trial.
Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
Vanhaverbeke M, Bogaerts K, Sinnaeve PR, Janssens L, Armstrong PW, Van de Werf F. Vanhaverbeke M, et al. Among authors: bogaerts k. Circulation. 2019 Jan 2;139(1):137-139. doi: 10.1161/CIRCULATIONAHA.118.036536. Circulation. 2019. PMID: 30586685 Review. No abstract available.
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2.
Garot P, Neylon A, Morice MC, Tamburino C, Bleiziffer S, Thiele H, Scholtz S, Schramm R, Cockburn J, Cunnington M, Wolf A, Barbanti M, Tchetché D, Pagnotta P, Gilard M, Bedogni F, Van Belle E, Vasa-Nicotera M, Chieffo A, Bogaerts K, Hengstenberg C, Capodanno D. Garot P, et al. Among authors: bogaerts k. EuroIntervention. 2022 Aug 19;18(6):503-513. doi: 10.4244/EIJ-D-21-01048. EuroIntervention. 2022. PMID: 35450838 Free PMC article. Clinical Trial.
The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) study optimizing pharmacoinvasive reperfusion strategy in older ST-elevation myocardial infarction patients.
Armstrong PW, Bogaerts K, Welsh R, Sinnaeve PR, Goldstein P, Pages A, Danays T, Van de Werf F; STREAM 2 Study Groups (appendix). Armstrong PW, et al. Among authors: bogaerts k. Am Heart J. 2020 Aug;226:140-146. doi: 10.1016/j.ahj.2020.04.029. Epub 2020 May 15. Am Heart J. 2020. PMID: 32553932
Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.
Varenne O, Cook S, Sideris G, Kedev S, Cuisset T, Carrié D, Hovasse T, Garot P, El Mahmoud R, Spaulding C, Helft G, Diaz Fernandez JF, Brugaletta S, Pinar-Bermudez E, Mauri Ferre J, Commeau P, Teiger E, Bogaerts K, Sabate M, Morice MC, Sinnaeve PR; SENIOR investigators. Varenne O, et al. Among authors: bogaerts k. Lancet. 2018 Jan 6;391(10115):41-50. doi: 10.1016/S0140-6736(17)32713-7. Epub 2017 Nov 1. Lancet. 2018. PMID: 29102362 Clinical Trial.
Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease.
Lafont A, Sinnaeve PR, Cuisset T, Cook S, Sideris G, Kedev S, Carrie D, Hovasse T, Garot P, El Mahmoud R, Spaulding C, Helft G, Diaz Fernandez JF, Brugaletta S, Pinar-Bermudez E, Ferre JM, Commeau P, Teiger E, Bogaerts K, Sabate M, Morice MC, Varenne O; SENIOR investigators. Lafont A, et al. Among authors: bogaerts k. Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E607-E613. doi: 10.1002/ccd.29159. Epub 2020 Aug 6. Catheter Cardiovasc Interv. 2021. PMID: 32761890 Free article. Clinical Trial.
147 results